Mitochondria-in-a-capsule: New therapy fights disease

Chinese scientists have developed a novel mitochondrial capsule transplantation therapy, successfully delivering healthy mitochondria into cells and tissues. This breakthrough, published in Cell, offers a new strategy for regenerative medicine, targeting diseases caused by mitochondrial dysfunction.

The therapy encapsulates healthy mitochondria within red blood cell membranes, creating tiny capsules that protect the organelles and facilitate cell entry. This method boasts an 80% delivery efficiency, a significant improvement over naked mitochondria.

These transplanted mitochondria integrate with the cell's own network, restoring normal energy metabolism. Tests on patient cells showed reduced malfunctioning mitochondria and restored cellular function. The therapy also showed efficacy in disease animal models.

In Parkinson's disease mouse models, the therapy prevented neuronal death and restored motor abilities. For genetic mitochondrial diseases, it extended lifespan and rescued organ failures, paving the way for using healthy organelles as medicine.